Dr. Roger Goldstein, MD, FRCPC
Claim this profileWestpark Health Care Centre
Studies Lung Disease
Studies Idiopathic Pulmonary Fibrosis
4 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Roger Goldstein, MD, FRCPC is currently running
One-Legged vs Two-Legged Cycle Training
for Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles being trained together. By training one leg at a time, the patient does not have to breathe as much allowing each leg a better workout. Our groundwork suggests it may work in patients with IPF. This study will help decide whether one-legged exercise training is better at improving a patient's exercise endurance compared to the usual way of exercising with both legs at the same time.
Recruiting1 award N/A3 criteria
Arm and Leg Exercises
for Healthy Individuals
Fitness is an important determinant for health and influenced by using large muscles. Muscles respond to training. We want to know if adding arm exercise to leg exercise can provide a better training session for healthy individuals. If the strategy shows promise for healthy people then it might work for people with lung disease who have trouble training because of difficulty breathing. The purpose of this first study is to evaluate, in healthy people, a unique approach to training by determining if adding arm exercise to leg exercise can be endured longer than leg exercise alone.
Recruiting1 award N/A
More about Roger Goldstein, MD, FRCPC
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Roger Goldstein, MD, FRCPC has experience with
- 1-leg Cycle Training
- 2-leg Cycle Training
- Hip Exoskeleton
- Powered Assist Hip Exoskeleton
- ATouchAway™ Platform
Breakdown of trials Roger Goldstein, MD, FRCPC has run
Lung Disease
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roger Goldstein, MD, FRCPC specialize in?
Roger Goldstein, MD, FRCPC focuses on Lung Disease and Idiopathic Pulmonary Fibrosis. In particular, much of their work with Lung Disease has involved treating patients, or patients who are undergoing treatment.
Is Roger Goldstein, MD, FRCPC currently recruiting for clinical trials?
Yes, Roger Goldstein, MD, FRCPC is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Roger Goldstein, MD, FRCPC has studied deeply?
Yes, Roger Goldstein, MD, FRCPC has studied treatments such as 1-leg cycle training, 2-leg cycle training, Hip Exoskeleton.
What is the best way to schedule an appointment with Roger Goldstein, MD, FRCPC?
Apply for one of the trials that Roger Goldstein, MD, FRCPC is conducting.
What is the office address of Roger Goldstein, MD, FRCPC?
The office of Roger Goldstein, MD, FRCPC is located at: Westpark Health Care Centre, Toronto, Ontario M6M 2J5 Canada. This is the address for their practice at the Westpark Health Care Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.